INTERNATIONAL PATENT: ANAPTYSBIO, INC. FILES APPLICATION FOR "CD 122 BINDING AGENTS FOR INHIBITING AN IMMUNE RESPONSE IN CELIAC DISEASE OR RELATED CONDITIONS"

GENEVA, March 25 -- ANAPTYSBIO, INC. (10770 Wateridge Circle, Suite 210San Diego, California 92121) filed a patent application (PCT/US2025/046413) for "CD 122 BINDING AGENTS FOR INHIBITING AN IMMUNE RESPONSE IN CELIAC DISEASE OR RELATED CONDITIONS" on Sep 15, 2025. With publication no. WO/2026/060381, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAHL, Martin Edward (10770 Wateridge Circle, Suite 210San Diego, California 92121), PARMLEY, Stephen (10770 Wateridge Circle, Suite 210San Diego, California 92121), HARE, Eric ...